Diffusion Pharmaceuticals Inc. DFFN 1.15 0.03 (2.67%). NASDAQ Updated Jun 8, 2020 11:56 PM Real time Marvell Technology Group (MRVL) stock price quote, stock graph, news & analysis. Current and historical debt to equity ratio values for Microbot Medical (MBOT) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Microbot Medical debt/equity for the three months ending March 31, 2020 was 0.02 . Microbot Medical, Inc. is a pre-clinical medical device company, which engages in the research, design, development, and commercialization of micro-robotics assisted medical technologies. The firm carries out its operations through the ViRob and TipCat platforms. The ViRob platform technology is an autonomous crawling micro-robot that can be controlled remotely or within the body.
Compugen Ltd. shares rose more than 5% during Thursday's session after Cantor Fitzgerald initiated coverage on the stock with an Overweight rating and a price target of $10 per share, reflecting a
View target prices and earnings history for Microbot Medical Inc. [MBOT:US] with TMXmoney. Top. Home Market Activity Get Quotes Research PRINT HELP. Zacks Investment Research. analyst ratings/earnings by Zacks. Pier 1 Imports, Inc. PIR 0.14 0.03 (25.98%). NYSE Updated Jun 5, 2020 7:55 PM Consensus Rating for MBOT is STRONG BUY: Since many brokers have different rating systems, we maintain a standard system with an assigned numeric value from 1 to 5. Ratings are a translation of brokers' recommendations to the recommendation scale, which ranges from a rating of 1 (a strong buy) to a rating of 5 (a strong sell). HINGHAM, Mass., Dec. 31, 2019 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq:MBOT) closed its previously announced registered direct offering of 900,901 shares of its common stock at a purchase Nasdaq, Forbes.com, The LA Times, The Chicago Tribune, Seeking Alpha, Zacks Investment Research, The Motley Fool, Business Insider, Mashable.com, StockTwits, Venture Beat, The Fly on the Wall, and more To Create Presentation or Web-Ready Images. Once the chart has been created, you can use it in one of two ways: Download an Image MBOT - Microbot Medical Inc. , stock quotes, stock charts, news, financials, short interest, message boards, insiders, holders, calendars, competitors, historical
Get the latest Microbot Medical Inc. (MBOT) stock news and headlines to help you in your trading and investing decisions. The Zacks Analyst Blog Highlights: Agile Therapeutics, Air Industries
MBOT: Microbot Medical Inc Detailed Estimate. Get the latest Detailed Estimate from Zacks Investment Research. MBOT: Microbot Medical Inc. EPS. Get the latest EPS stock quote information from Zacks Investment Research. MBOT: Microbot Medical Inc broker recommendations. Get the latest broker recommendations from Zacks Investment Research. MBOT: Microbot Medical Inc - Full Company Report. Get the latest Full Company Report for Microbot Medical Inc from Zacks Investment Research Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. MBOT: Microbot Medical Inc broker recommendation chart. Get the latest chart with broker recommendations from Zacks Investment Research. Get the latest Microbot Medical Inc. (MBOT) stock news and headlines to help you in your trading and investing decisions. The Zacks Analyst Blog Highlights: Agile Therapeutics, Air Industries
The latest closing stock price for Microbot Medical as of June 08, 2020 is 7.23. The all-time high for the last 52 weeks is 6.68. Compare MBOT With Other Stocks Policy | Contact Us Fundamental data from Zacks Investment Research, Inc.
Stocks Analysis by Zacks Investment Research covering: S&P 500, Dow Jones Industrial Average, Cassava Sciences Inc, Microbot Medical Inc. Read Zacks Investment Research's latest article on Microbot Medical Inc. (MBOT) belonging to the Healthcare sector has surged 0.79% and closed its last trading session at $1.28. The company reported its EPS on 9/29/2016. Currently, the stock has a 1 Year Price Target of $198. The consensus recommendation, according to Zacks Investment research, is 0. The scale runs from 1 to 5 with 1 recommending Strong Buy and 5 recommending a Strong Sell Microbot Medical Inc. Announces Closing of $10.0 Million Registered Direct Offering of Common Stock GlobeNewswire 154d Microbot Medical shares slide on news of dilutive equity offering but remain
The Zacks Analyst Blog Highlights: Agile Therapeutics, Air Industries, Dermira, Microbot Medical and Cassava Sciences
According to Zacks Investment Research, based on 1 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.28. The reported EPS for the same quarter last year was $-0.48. Analyst Opinion on Microbot Medical Inc (NASDAQ:MBOT) 1 Wall Street analysts have issued ratings and price targets for Microbot Medical in the last 12 months The Zacks Analyst Blog Highlights: Agile Therapeutics, Air Industries, Dermira, Microbot Medical and Cassava Sciences Zacks Jan 10, 2020 GME, MDGL, MBOT and OLLI among midday movers Seeking Alpha Microbot Medical Inc. (Nasdaq:MBOT) closed its previously announced registered direct offering of 900,901 shares of its common stock at a purchase price of $11.10 per share for total gross proceeds of 1 Wall Street analysts have issued ratings and price targets for Microbot Medical in the last 12 months. Their average twelve-month price target is $19.00, suggesting that the stock has a possible upside of 162.43%. The high price target for MBOT is $19.00 and the low price target for MBOT is $19.00.